Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

dc.contributor.author	Husby, Anders
dc.contributor.author	Gulseth, Hanne Løvdal
dc.contributor.author	Hovi, Petteri
dc.contributor.author	Hansen, Jørgen Vinsløv
dc.contributor.author	Pihlstrøm, Nicklas
dc.contributor.author	Gunnes, Nina
dc.contributor.author	Härkänen, Tommi
dc.contributor.author	Dahl, Jesper
dc.contributor.author	Karlstad, Øystein
dc.contributor.author	Heliö, Tiina
dc.contributor.author	Køber, Lars
dc.contributor.author	Ljung, Rickard
dc.contributor.author	Hviid, Anders
dc.date.accessioned	2023-04-28T11:42:36Z
dc.date.available	2023-04-28T11:42:36Z
dc.date.created	2023-03-27T12:37:18Z
dc.date.issued	2023
dc.identifier.issn	2754-0413
dc.identifier.uri	https://hdl.handle.net/11250/3065559
dc.language.iso	eng
dc.title	Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
dc.title.alternative	Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.journal	BMJ Medicine
dc.identifier.doi	10.1136/bmjmed-2022-000373
dc.identifier.cristin	2137183
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1